Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
US Market
Holding EMMA?
Track your performance easily

Emmaus Life Sciences (EMMA) Financial Statements

86 Followers

Emmaus Life Sciences Financial Overview

Emmaus Life Sciences's market cap is currently ―. The company's EPS TTM is $-0.084; its P/E ratio is -0.19; Emmaus Life Sciences is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 5.38M$ 2.51M$ 7.07M$ 5.02M$ 10.76M
Gross Profit$ 5.14M$ 2.25M$ 6.88M$ 4.80M$ 10.25M
EBIT$ -1.19M$ -2.40M$ 6.07M$ -1.64M$ 277.00K
EBITDA$ -1.11M$ -1.90M$ 6.80M$ -1.05M$ 970.00K
Net Income Common Stockholders$ -2.18M$ -4.30M$ 1.24M$ 67.00K$ -1.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.52M$ 1.71M$ 2.55M$ 1.50M$ 1.36M
Total Assets$ 25.94M$ 29.54M$ 35.18M$ 47.45M$ 50.30M
Total Debt$ 18.55M$ 19.02M$ 19.09M$ 2.90M$ 32.67M
Net Debt$ 17.03M$ 17.31M$ 16.54M$ 1.40M$ 31.30M
Total Liabilities$ 82.95M$ 83.19M$ 69.37M$ 83.78M$ 85.32M
Stockholders Equity$ -57.01M$ -53.64M$ -47.76M$ -36.33M$ -35.03M
Cash Flow-
Free Cash Flow$ -2.92M$ 136.00K$ 1.03M$ 58.00K$ -1.32M
Operating Cash Flow$ -2.92M$ 140.00K$ 1.04M$ 58.00K$ -1.32M
Investing Cash Flow$ 2.50M$ -4.00K$ -6.00K$ -399.00K$ 1.06M
Financing Cash Flow$ 235.00K$ -955.00K$ -5.00K$ 494.00K$ -153.00K
Currency in USD

Emmaus Life Sciences Earnings and Revenue History

Emmaus Life Sciences Debt to Assets

Emmaus Life Sciences Cash Flow

Emmaus Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis